Wouter Van Rijs
Dr. Molewaterplein 40
Rotterdam, ZH 3015GD, Netherlands
Rotterdam, ZH 3015GD, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Genetic variation of low-to-medium-affinity Fc-gamma receptors in Guillain-Barré syndrome.
Journal: Journal of neurology
Published: December 13, 2024
Large-scale profiling of antibody reactivity to glycolipids in patients with Guillain-Barré syndrome.
Journal: Brain : a journal of neurology
Published: November 08, 2024
High and Persistent Anti-GM1 Antibody Titers Are Associated With Poor Clinical Recovery in Guillain-Barré Syndrome.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: October 10, 2022
Genetic biomarkers for intravenous immunoglobulin response in chronic inflammatory demyelinating polyradiculoneuropathy.
Journal: European journal of neurology
Published: December 11, 2020
IVIg-induced plasmablasts in patients with Guillain-Barré syndrome.
Journal: Annals of clinical and translational neurology
Published: August 15, 2018
Neonatal Fc receptor promoter gene polymorphism does not predict pharmacokinetics of IVIg or the clinical course of GBS.
Journal: Annals of clinical and translational neurology
Published: March 18, 2016
Innate Immunity to Campylobacter jejuni in Guillain-Barré Syndrome.
Journal: Annals of neurology
Published: December 05, 2014
IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins.
Journal: Journal of proteome research
Published: February 19, 2014
Sialylation of Campylobacter jejuni endotoxin promotes dendritic cell-mediated B cell responses through CD14-dependent production of IFN-β and TNF-α.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: October 30, 2013
Serum IgG levels in IV immunoglobulin treated chronic inflammatory demyelinating polyneuropathy.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: March 30, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026